2021
DOI: 10.1186/s42358-021-00185-5
|View full text |Cite
|
Sign up to set email alerts
|

Letter to the editor re: prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…The multiplicity of data present at the time of diagnosis and the characteristics of the biological treatment per year add important information to the initiatives of Latin America to respond to challenges in the field of SpA, such as real-world evidence and the development of centers of excellence. 34,35 In conclusion, in our cohort, half of the patients with axSpA were nr-axSpA at the time of diagnosis, with no differences found in terms of clinical characteristics, disease activity, functional capacity, or treatment at 1 year. The only differences found were the fact that patients with AS had a longer delay to diagnosis and the higher proportion of men.…”
Section: Ta B L E 2 (Continued)mentioning
confidence: 61%
See 1 more Smart Citation
“…The multiplicity of data present at the time of diagnosis and the characteristics of the biological treatment per year add important information to the initiatives of Latin America to respond to challenges in the field of SpA, such as real-world evidence and the development of centers of excellence. 34,35 In conclusion, in our cohort, half of the patients with axSpA were nr-axSpA at the time of diagnosis, with no differences found in terms of clinical characteristics, disease activity, functional capacity, or treatment at 1 year. The only differences found were the fact that patients with AS had a longer delay to diagnosis and the higher proportion of men.…”
Section: Ta B L E 2 (Continued)mentioning
confidence: 61%
“…However, the structured and complete evaluation in terms of clinical, laboratory, and imaging features for all the patients allows for a comprehensive characterization with complete data, in patients with and without radiological involvement alike and may be considered as a strength for this study. The multiplicity of data present at the time of diagnosis and the characteristics of the biological treatment per year add important information to the initiatives of Latin America to respond to challenges in the field of SpA, such as real‐world evidence and the development of centers of excellence 34,35 …”
Section: Discussionmentioning
confidence: 99%